Consultant, Department of Medical Oncology, The Christie NHS Foundation Trust, Wilmslow Road, Withington, Manchester M20 4BX, UK.
Ther Adv Med Oncol. 2011 Jan;3(1):43-52. doi: 10.1177/1758834010388342.
As the therapeutic options for the treatment of colorectal cancer have expanded over the past 20 years, so has the complexity of decision making. The goals of treatment in the palliative, adjuvant and neoadjuvant settings vary and it is not only the efficacy of drugs that influence treatment decisions. Age, performance status, the presence of significant comorbidities and the different treatment regimens and strategies provide medical oncologists with an array of options to attempt to maximize patients' quality of life and longevity.
随着过去 20 年来治疗结直肠癌的治疗选择的不断扩展，决策的复杂性也在增加。姑息治疗、辅助治疗和新辅助治疗的目标不同，影响治疗决策的不仅是药物的疗效。年龄、体能状态、是否存在严重合并症以及不同的治疗方案和策略为肿瘤内科医生提供了一系列的选择，以尽量提高患者的生活质量和延长寿命。
